0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Internal Neuromodulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-24F2529
Home | Market Reports | Health| Health Conditions| Pain Management
Global Internal Neuromodulation Market Insights and Forecast to 2028
BUY CHAPTERS

Internal Neuromodulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24F2529
Report
September 2024
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Internal Neuromodulation - Market Size

The global market for Internal Neuromodulation was estimated to be worth US$ 2102 million in 2023 and is forecast to a readjusted size of US$ 3542.4 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030

Internal Neuromodulation - Market

Internal Neuromodulation - Market

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Internal Neuromodulation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Internal Neuromodulation by region & country, by Type, and by Application.
The Internal Neuromodulation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Internal Neuromodulation.
Market Segmentation

Scope of Internal Neuromodulation - Market Report

Report Metric Details
Report Name Internal Neuromodulation - Market
Forecasted market size in 2030 US$ 3542.4 million
CAGR 7.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Neuro Stimulator
Segment by Application
  • Parkinsons Disease
  • Chronic Pain
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch, Abbott Laboratories, Nevro Corporation, NeuroSigma, MicroTransponder, Neuronetics, LivaNova PLC, Bioventus Inc, NeuroPace Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Internal Neuromodulation manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Internal Neuromodulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Internal Neuromodulation in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Internal Neuromodulation - Market size in 2030?

Ans: The Internal Neuromodulation - Market size in 2030 will be US$ 3542.4 million.

Who are the main players in the Internal Neuromodulation - Market report?

Ans: The main players in the Internal Neuromodulation - Market are Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch, Abbott Laboratories, Nevro Corporation, NeuroSigma, MicroTransponder, Neuronetics, LivaNova PLC, Bioventus Inc, NeuroPace Inc

What are the Application segmentation covered in the Internal Neuromodulation - Market report?

Ans: The Applications covered in the Internal Neuromodulation - Market report are Parkinsons Disease, Chronic Pain, Others

What are the Type segmentation covered in the Internal Neuromodulation - Market report?

Ans: The Types covered in the Internal Neuromodulation - Market report are Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator

1 Market Overview
1.1 Internal Neuromodulation Product Introduction
1.2 Global Internal Neuromodulation Market Size Forecast
1.3 Internal Neuromodulation Market Trends & Drivers
1.3.1 Internal Neuromodulation Industry Trends
1.3.2 Internal Neuromodulation Market Drivers & Opportunity
1.3.3 Internal Neuromodulation Market Challenges
1.3.4 Internal Neuromodulation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Internal Neuromodulation Players Revenue Ranking (2023)
2.2 Global Internal Neuromodulation Revenue by Company (2019-2024)
2.3 Key Companies Internal Neuromodulation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Internal Neuromodulation Product Offered
2.5 Key Companies Time to Begin Mass Production of Internal Neuromodulation
2.6 Internal Neuromodulation Market Competitive Analysis
2.6.1 Internal Neuromodulation Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Internal Neuromodulation Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Spinal Cord Stimulator
3.1.2 Deep Brain Stimulator
3.1.3 Sacral Nerve Stimulator
3.1.4 Vagus Nerve Stimulator
3.1.5 Gastric Neuro Stimulator
3.2 Global Internal Neuromodulation Sales Value by Type
3.2.1 Global Internal Neuromodulation Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Internal Neuromodulation Sales Value, by Type (2019-2030)
3.2.3 Global Internal Neuromodulation Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Parkinsons Disease
4.1.2 Chronic Pain
4.1.3 Others
4.2 Global Internal Neuromodulation Sales Value by Application
4.2.1 Global Internal Neuromodulation Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Internal Neuromodulation Sales Value, by Application (2019-2030)
4.2.3 Global Internal Neuromodulation Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Internal Neuromodulation Sales Value by Region
5.1.1 Global Internal Neuromodulation Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Internal Neuromodulation Sales Value by Region (2019-2024)
5.1.3 Global Internal Neuromodulation Sales Value by Region (2025-2030)
5.1.4 Global Internal Neuromodulation Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Internal Neuromodulation Sales Value, 2019-2030
5.2.2 North America Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Internal Neuromodulation Sales Value, 2019-2030
5.3.2 Europe Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Internal Neuromodulation Sales Value, 2019-2030
5.4.2 Asia Pacific Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Internal Neuromodulation Sales Value, 2019-2030
5.5.2 South America Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Internal Neuromodulation Sales Value, 2019-2030
5.6.2 Middle East & Africa Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Internal Neuromodulation Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Internal Neuromodulation Sales Value
6.3 United States
6.3.1 United States Internal Neuromodulation Sales Value, 2019-2030
6.3.2 United States Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Internal Neuromodulation Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Internal Neuromodulation Sales Value, 2019-2030
6.4.2 Europe Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Internal Neuromodulation Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Internal Neuromodulation Sales Value, 2019-2030
6.5.2 China Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
6.5.3 China Internal Neuromodulation Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Internal Neuromodulation Sales Value, 2019-2030
6.6.2 Japan Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Internal Neuromodulation Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Internal Neuromodulation Sales Value, 2019-2030
6.7.2 South Korea Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Internal Neuromodulation Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Internal Neuromodulation Sales Value, 2019-2030
6.8.2 Southeast Asia Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Internal Neuromodulation Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Internal Neuromodulation Sales Value, 2019-2030
6.9.2 India Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
6.9.3 India Internal Neuromodulation Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic PLC
7.1.1 Medtronic PLC Profile
7.1.2 Medtronic PLC Main Business
7.1.3 Medtronic PLC Internal Neuromodulation Products, Services and Solutions
7.1.4 Medtronic PLC Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.1.5 Medtronic PLC Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Internal Neuromodulation Products, Services and Solutions
7.2.4 Abbott Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Boston Scientific Corp.
7.3.1 Boston Scientific Corp. Profile
7.3.2 Boston Scientific Corp. Main Business
7.3.3 Boston Scientific Corp. Internal Neuromodulation Products, Services and Solutions
7.3.4 Boston Scientific Corp. Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.3.5 Cerbomed GMBH Recent Developments
7.4 Cerbomed GMBH
7.4.1 Cerbomed GMBH Profile
7.4.2 Cerbomed GMBH Main Business
7.4.3 Cerbomed GMBH Internal Neuromodulation Products, Services and Solutions
7.4.4 Cerbomed GMBH Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.4.5 Cerbomed GMBH Recent Developments
7.5 Cyberonics
7.5.1 Cyberonics Profile
7.5.2 Cyberonics Main Business
7.5.3 Cyberonics Internal Neuromodulation Products, Services and Solutions
7.5.4 Cyberonics Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.5.5 Cyberonics Recent Developments
7.6 Biocontrol Medical
7.6.1 Biocontrol Medical Profile
7.6.2 Biocontrol Medical Main Business
7.6.3 Biocontrol Medical Internal Neuromodulation Products, Services and Solutions
7.6.4 Biocontrol Medical Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.6.5 Biocontrol Medical Recent Developments
7.7 Depuy Synthes Companies
7.7.1 Depuy Synthes Companies Profile
7.7.2 Depuy Synthes Companies Main Business
7.7.3 Depuy Synthes Companies Internal Neuromodulation Products, Services and Solutions
7.7.4 Depuy Synthes Companies Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.7.5 Depuy Synthes Companies Recent Developments
7.8 Enteromedics
7.8.1 Enteromedics Profile
7.8.2 Enteromedics Main Business
7.8.3 Enteromedics Internal Neuromodulation Products, Services and Solutions
7.8.4 Enteromedics Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.8.5 Enteromedics Recent Developments
7.9 Synapse Biomedical
7.9.1 Synapse Biomedical Profile
7.9.2 Synapse Biomedical Main Business
7.9.3 Synapse Biomedical Internal Neuromodulation Products, Services and Solutions
7.9.4 Synapse Biomedical Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.9.5 Synapse Biomedical Recent Developments
7.10 Uroplasty
7.10.1 Uroplasty Profile
7.10.2 Uroplasty Main Business
7.10.3 Uroplasty Internal Neuromodulation Products, Services and Solutions
7.10.4 Uroplasty Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.10.5 Uroplasty Recent Developments
7.11 Greatbatch
7.11.1 Greatbatch Profile
7.11.2 Greatbatch Main Business
7.11.3 Greatbatch Internal Neuromodulation Products, Services and Solutions
7.11.4 Greatbatch Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.11.5 Greatbatch Recent Developments
7.12 Abbott Laboratories
7.12.1 Abbott Laboratories Profile
7.12.2 Abbott Laboratories Main Business
7.12.3 Abbott Laboratories Internal Neuromodulation Products, Services and Solutions
7.12.4 Abbott Laboratories Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.12.5 Abbott Laboratories Recent Developments
7.13 Nevro Corporation
7.13.1 Nevro Corporation Profile
7.13.2 Nevro Corporation Main Business
7.13.3 Nevro Corporation Internal Neuromodulation Products, Services and Solutions
7.13.4 Nevro Corporation Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.13.5 Nevro Corporation Recent Developments
7.14 NeuroSigma
7.14.1 NeuroSigma Profile
7.14.2 NeuroSigma Main Business
7.14.3 NeuroSigma Internal Neuromodulation Products, Services and Solutions
7.14.4 NeuroSigma Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.14.5 NeuroSigma Recent Developments
7.15 MicroTransponder
7.15.1 MicroTransponder Profile
7.15.2 MicroTransponder Main Business
7.15.3 MicroTransponder Internal Neuromodulation Products, Services and Solutions
7.15.4 MicroTransponder Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.15.5 MicroTransponder Recent Developments
7.16 Neuronetics
7.16.1 Neuronetics Profile
7.16.2 Neuronetics Main Business
7.16.3 Neuronetics Internal Neuromodulation Products, Services and Solutions
7.16.4 Neuronetics Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.16.5 Neuronetics Recent Developments
7.17 LivaNova PLC
7.17.1 LivaNova PLC Profile
7.17.2 LivaNova PLC Main Business
7.17.3 LivaNova PLC Internal Neuromodulation Products, Services and Solutions
7.17.4 LivaNova PLC Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.17.5 LivaNova PLC Recent Developments
7.18 Bioventus Inc
7.18.1 Bioventus Inc Profile
7.18.2 Bioventus Inc Main Business
7.18.3 Bioventus Inc Internal Neuromodulation Products, Services and Solutions
7.18.4 Bioventus Inc Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.18.5 Bioventus Inc Recent Developments
7.19 NeuroPace Inc
7.19.1 NeuroPace Inc Profile
7.19.2 NeuroPace Inc Main Business
7.19.3 NeuroPace Inc Internal Neuromodulation Products, Services and Solutions
7.19.4 NeuroPace Inc Internal Neuromodulation Revenue (US$ Million) & (2019-2024)
7.19.5 NeuroPace Inc Recent Developments
8 Industry Chain Analysis
8.1 Internal Neuromodulation Industrial Chain
8.2 Internal Neuromodulation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Internal Neuromodulation Sales Model
8.5.2 Sales Channel
8.5.3 Internal Neuromodulation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Internal Neuromodulation Market Trends
    Table 2. Internal Neuromodulation Market Drivers & Opportunity
    Table 3. Internal Neuromodulation Market Challenges
    Table 4. Internal Neuromodulation Market Restraints
    Table 5. Global Internal Neuromodulation Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Internal Neuromodulation Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Internal Neuromodulation Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Internal Neuromodulation Product Type
    Table 9. Key Companies Time to Begin Mass Production of Internal Neuromodulation
    Table 10. Global Internal Neuromodulation Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Internal Neuromodulation Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Internal Neuromodulation Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Internal Neuromodulation Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Internal Neuromodulation Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Internal Neuromodulation Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Internal Neuromodulation Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Internal Neuromodulation Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Internal Neuromodulation Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Internal Neuromodulation Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Internal Neuromodulation Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Internal Neuromodulation Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Internal Neuromodulation Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Internal Neuromodulation Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Internal Neuromodulation Sales Value by Region (2019-2024) & (%)
    Table 27. Global Internal Neuromodulation Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Internal Neuromodulation Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Internal Neuromodulation Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Internal Neuromodulation Sales Value, (2025-2030) & (US$ Million)
    Table 31. Medtronic PLC Basic Information List
    Table 32. Medtronic PLC Description and Business Overview
    Table 33. Medtronic PLC Internal Neuromodulation Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Internal Neuromodulation Business of Medtronic PLC (2019-2024)
    Table 35. Medtronic PLC Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott Internal Neuromodulation Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Internal Neuromodulation Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. Boston Scientific Corp. Basic Information List
    Table 42. Boston Scientific Corp. Description and Business Overview
    Table 43. Boston Scientific Corp. Internal Neuromodulation Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Internal Neuromodulation Business of Boston Scientific Corp. (2019-2024)
    Table 45. Boston Scientific Corp. Recent Developments
    Table 46. Cerbomed GMBH Basic Information List
    Table 47. Cerbomed GMBH Description and Business Overview
    Table 48. Cerbomed GMBH Internal Neuromodulation Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Internal Neuromodulation Business of Cerbomed GMBH (2019-2024)
    Table 50. Cerbomed GMBH Recent Developments
    Table 51. Cyberonics Basic Information List
    Table 52. Cyberonics Description and Business Overview
    Table 53. Cyberonics Internal Neuromodulation Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Internal Neuromodulation Business of Cyberonics (2019-2024)
    Table 55. Cyberonics Recent Developments
    Table 56. Biocontrol Medical Basic Information List
    Table 57. Biocontrol Medical Description and Business Overview
    Table 58. Biocontrol Medical Internal Neuromodulation Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Internal Neuromodulation Business of Biocontrol Medical (2019-2024)
    Table 60. Biocontrol Medical Recent Developments
    Table 61. Depuy Synthes Companies Basic Information List
    Table 62. Depuy Synthes Companies Description and Business Overview
    Table 63. Depuy Synthes Companies Internal Neuromodulation Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Internal Neuromodulation Business of Depuy Synthes Companies (2019-2024)
    Table 65. Depuy Synthes Companies Recent Developments
    Table 66. Enteromedics Basic Information List
    Table 67. Enteromedics Description and Business Overview
    Table 68. Enteromedics Internal Neuromodulation Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Internal Neuromodulation Business of Enteromedics (2019-2024)
    Table 70. Enteromedics Recent Developments
    Table 71. Synapse Biomedical Basic Information List
    Table 72. Synapse Biomedical Description and Business Overview
    Table 73. Synapse Biomedical Internal Neuromodulation Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Internal Neuromodulation Business of Synapse Biomedical (2019-2024)
    Table 75. Synapse Biomedical Recent Developments
    Table 76. Uroplasty Basic Information List
    Table 77. Uroplasty Description and Business Overview
    Table 78. Uroplasty Internal Neuromodulation Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Internal Neuromodulation Business of Uroplasty (2019-2024)
    Table 80. Uroplasty Recent Developments
    Table 81. Greatbatch Basic Information List
    Table 82. Greatbatch Description and Business Overview
    Table 83. Greatbatch Internal Neuromodulation Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Internal Neuromodulation Business of Greatbatch (2019-2024)
    Table 85. Greatbatch Recent Developments
    Table 86. Abbott Laboratories Basic Information List
    Table 87. Abbott Laboratories Description and Business Overview
    Table 88. Abbott Laboratories Internal Neuromodulation Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Internal Neuromodulation Business of Abbott Laboratories (2019-2024)
    Table 90. Abbott Laboratories Recent Developments
    Table 91. Nevro Corporation Basic Information List
    Table 92. Nevro Corporation Description and Business Overview
    Table 93. Nevro Corporation Internal Neuromodulation Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Internal Neuromodulation Business of Nevro Corporation (2019-2024)
    Table 95. Nevro Corporation Recent Developments
    Table 96. NeuroSigma Basic Information List
    Table 97. NeuroSigma Description and Business Overview
    Table 98. NeuroSigma Internal Neuromodulation Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Internal Neuromodulation Business of NeuroSigma (2019-2024)
    Table 100. NeuroSigma Recent Developments
    Table 101. MicroTransponder Basic Information List
    Table 102. MicroTransponder Description and Business Overview
    Table 103. MicroTransponder Internal Neuromodulation Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Internal Neuromodulation Business of MicroTransponder (2019-2024)
    Table 105. MicroTransponder Recent Developments
    Table 106. Neuronetics Basic Information List
    Table 107. Neuronetics Description and Business Overview
    Table 108. Neuronetics Internal Neuromodulation Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Internal Neuromodulation Business of Neuronetics (2019-2024)
    Table 110. Neuronetics Recent Developments
    Table 111. LivaNova PLC Basic Information List
    Table 112. LivaNova PLC Description and Business Overview
    Table 113. LivaNova PLC Internal Neuromodulation Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Internal Neuromodulation Business of LivaNova PLC (2019-2024)
    Table 115. LivaNova PLC Recent Developments
    Table 116. Bioventus Inc Basic Information List
    Table 117. Bioventus Inc Description and Business Overview
    Table 118. Bioventus Inc Internal Neuromodulation Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Internal Neuromodulation Business of Bioventus Inc (2019-2024)
    Table 120. Bioventus Inc Recent Developments
    Table 121. NeuroPace Inc Basic Information List
    Table 122. NeuroPace Inc Description and Business Overview
    Table 123. NeuroPace Inc Internal Neuromodulation Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Internal Neuromodulation Business of NeuroPace Inc (2019-2024)
    Table 125. NeuroPace Inc Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. Internal Neuromodulation Downstream Customers
    Table 129. Internal Neuromodulation Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Internal Neuromodulation Product Picture
    Figure 2. Global Internal Neuromodulation Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Internal Neuromodulation Sales Value (2019-2030) & (US$ Million)
    Figure 4. Internal Neuromodulation Report Years Considered
    Figure 5. Global Internal Neuromodulation Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Internal Neuromodulation Revenue in 2023
    Figure 7. Internal Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Spinal Cord Stimulator Picture
    Figure 9. Deep Brain Stimulator Picture
    Figure 10. Sacral Nerve Stimulator Picture
    Figure 11. Vagus Nerve Stimulator Picture
    Figure 12. Gastric Neuro Stimulator Picture
    Figure 13. Global Internal Neuromodulation Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Internal Neuromodulation Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Parkinsons Disease
    Figure 16. Product Picture of Chronic Pain
    Figure 17. Product Picture of Others
    Figure 18. Global Internal Neuromodulation Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Internal Neuromodulation Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Internal Neuromodulation Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Internal Neuromodulation Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Internal Neuromodulation Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Internal Neuromodulation Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Internal Neuromodulation Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Internal Neuromodulation Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Internal Neuromodulation Sales Value (%), (2019-2030)
    Figure 31. United States Internal Neuromodulation Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Internal Neuromodulation Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Internal Neuromodulation Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Internal Neuromodulation Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Internal Neuromodulation Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Internal Neuromodulation Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Internal Neuromodulation Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Internal Neuromodulation Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Internal Neuromodulation Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Internal Neuromodulation Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Internal Neuromodulation Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Internal Neuromodulation Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Internal Neuromodulation Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Internal Neuromodulation Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Internal Neuromodulation Sales Value by Application (%), 2023 VS 2030
    Figure 52. Internal Neuromodulation Industrial Chain
    Figure 53. Internal Neuromodulation Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS